Anti-inflammatory and antiviral effects of Extracellular Vesicles derived from macrophages treated with the neuropeptides VIP and PACAP in SARS-CoV-2 infected monocytes

Vol 1, 2024 - 305871
Poster
Favorite this paper
How to cite this paper?
Abstract

Extracellular vesicles (EVs) are cellular structures released of endosomes or membrane budding. Classified according to their size, origin, and density, EVs can be divided into large vesicles (>200 nm) and small vesicles (<150 nm). Studies with immune cell derived EVs show functions, such as antimicrobial activities and regulation of the inflammatory response. Previous studies have demonstrated that EVs secreted by different cellular sources play important roles during SARS-CoV-2 infection, leading to both stimulatory and inhibitory activities. In this study, we used macrophages derived from circulating monocytes of blood donors to obtain EVs, the experimental procedures using human cells from healthy individuals were approved by the Research Ethics Committee of the Oswaldo Cruz Foundation / FIOCRUZ (Rio de Janeiro, RJ, Brazil) under the number 49971421.8.0000.5248, on behalf of Dumith Chequer Bou-Habib. In previous studies, we observed that VIP and PACAP, two endogenous neuropeptides, could inhibit SARS-CoV-2 replication in monocytes, as well as reduce the production of proinflammatory mediators in virus-infected cells. Therefore, we investigated whether EVs obtained from macrophages treated with VIP or PACAP could control the effects related to SARS-CoV-2 infection in primary monocytes. The EVs derived from macrophages were isolated by differential centrifugation of conditioned medium collected from primary cells cultured for 24 hours, divided into three stages of differential ultracentrifugation (20,000g and 110,000g), to obtain and separate the population of large vesicles and small vesicles. Monocytes were infected with SARS-CoV-2 (GenBank accession no. MT710714) at MOI of 0.01 for 1h, then exposed to pools of large or small vesicles from untreated, VIP-stimulated or PACAP-stimulated macrophages at the concentrations ranging from 30 -70 μg/mL. After 24h, the citokine levels and NF-kB activation were measured in the culture supernatant by ELISA, viral RNA levels were detected by Real-Time PCR and cellular viability was measured by LDH. We observed that EVs could transmit antiviral effects to virus-infected monocytes, as evidenced by the decrease in SARS-CoV-2 RNA synthesis/replication in human monocytes, protected these cells from virus-induced cytopathic effects, and reduced the production of proinflammatory mediators, in the reduction of levels of IL-6, IL-8, and TNF-α. We further observed that EVs prevented the SARS-CoV-2-induced NF-kB activation in monocytes, which is critically involved in the production of inflammatory mediators. Our findings suggest that EVs are endowed with immunoregulatory properties that might contribute to the antiviral response against SARS-CoV-2-infected monocytes and expand our knowledge of the regulation and effects of extracellular vesicles during COVID-19 pathogenesis.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 Laboratory on Thymus Research, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro/RJ, Brazil
  • 2 Laboratory on Thymus Research, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro, Brazil,
  • 3 Laboratory of Cellular Biology, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro
  • 4 Fiocruz
  • 5 Brazil Laboratory of Immunopharmacology, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro
Research Topic
  • Immune response
Keywords
Extracellular vesicles
VIP
PACAP
Macrophages
SARS-CoV-2